KK
Kevin Koch
President and CEO

Kevin Koch insider trades: Edgewise Therapeutics (EWTX) stock sales

President and CEO, Edgewise Therapeutics Last trade Aug 12, 2026 35 Form 4 filings
$785K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2006
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 12, 2026EWTX↓ Sell$785K
Aug 12, 2025EWTX↓ Sell$107K
May 2, 2025EWTX↓ Sell$70K
Mar 7, 2025EWTX↓ Sell$3K
Feb 6, 2025EWTX↓ Sell$287K
May 2, 2024EWTX↓ Sell$60K
May 2, 2023EWTX↓ Sell$29K
Feb 5, 2007ARRY↓ Sell$281K
Jan 19, 2007ARRY↓ Sell$377K
Feb 17, 2006ARRY↓ Sell$188K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other EWTX insiders

Open-market trades in the last 12 months

About Kevin Koch's insider trades

Kevin Koch is President and CEO at Edgewise Therapeutics (EWTX). Since Feb 17, 2006, Kevin has reported no open-market purchases and 10 sales worth $2.2M on SEC Form 4. In the last 12 months: 1 sale ($785K).

Their filings also include grants and awards (22 filings), option exercises (12 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EWTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.